Twist Bioscience (TWST) Cash from Operations (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Cash from Operations data on file, last reported at 17559000.0 in Q1 2026.

• Cash from Operations for Q1 2026 came in at 17559000.0, down 35.21% year-over-year; the trailing twelve-month figure through Mar 2026 was 55587000.0 (up 0.94% YoY), and the FY2025 annual result was 47628000.0, up 25.69% from the prior year.
• Cash from Operations grew to 17559000.0 in Q1 2026 per TWST's latest filing, from 24814000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 1267000.0 in Q3 2022 and troughed at 54070000.0 in Q4 2022.
• A 5-year average of 22017705.88 and a median of 20704000.0 in 2023 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations jumped 96.36% in 2022, then sank 1534.1% in 2023.
• A 5-year view of Cash from Operations shows it stood at 54070000.0 in 2022, then surged by 57.51% to 22973000.0 in 2023, then climbed by 6.73% to 21428000.0 in 2024, then declined by 15.8% to 24814000.0 in 2025, then rose by 29.24% to 17559000.0 in 2026.
• Business Quant data shows TWST's Cash from Operations at 17559000.0 in Q1 2026, 24814000.0 in Q4 2025, and 11814000.0 in Q3 2025.